This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Masafumi Tomaki: Innovator in Respiratory Disease Treatment
Introduction
Masafumi Tomaki is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of medicine, particularly in the development of treatments for respiratory diseases. His innovative approach has led to the creation of a patent that addresses critical health issues.
Latest Patents
Masafumi Tomaki holds a patent for a preventive and remedial compound for respiratory diseases. This invention aims to provide a compound that inhibits the activity of specific proteins associated with respiratory conditions. The patent includes various components such as compounds that inhibit gene expression, antisense nucleotides, and antibodies targeting the relevant proteins. These innovations are intended to serve as prophylactic and therapeutic agents for respiratory diseases.
Career Highlights
Tomaki is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda has allowed him to focus on developing innovative solutions for complex health challenges. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.
Collaborations
Masafumi Tomaki collaborates with esteemed colleagues, including Masakazu Ichinose and Hiromasa Ogawa. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Masafumi Tomaki's contributions to the field of respiratory disease treatment exemplify the impact of innovation in healthcare. His patent and ongoing work at Takeda Pharmaceutical Company Limited highlight the importance of research in developing effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
